Cite
HARVARD Citation
Kelly, R. et al. (n.d.). Short‐term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes. Diabetes, obesity & metabolism. 17 (4), pp. 414-422. [Online].